P8IP
GH icon

Pier 88 Investment Partners’s Guardant Health GH Stock Holding History

Pier 88 Investment Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Sell
6,400
-1,800
-22% -$196K 0.23% 33
2026
Q1 		$757K Buy
8,200
+1,380
+20% +$139K 0.19% 57
2025
Q4 		$697K Sell
6,820
-9,830
-59% -$879K 0.16% 71
2025
Q3 		$1.04M Buy
16,650
+4,250
+34% +$231K 0.2% 57
2025
Q2 		$645K Buy
+12,400
New +$554K 0.12% 75

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Pier 88 Investment Partners's GH Position: Q2 2026 in Review

Pier 88 Investment Partners reduced its Guardant Health (GH) stake by 22% in Q2 2026, selling an estimated $196K and leaving 6,400 shares worth $960K. The position accounts for 0.23% of the portfolio, ranked #33.

Pier 88 Investment Partners first reported a position in GH in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.04M in Q3 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Pier 88 Investment Partners held 6,400 shares of Guardant Health worth $960K as of Q2 2026.
  • Pier 88 Investment Partners sold 1,800 Guardant Health shares in Q2 2026, an estimated $196K.
  • Guardant Health made up 0.23% of Pier 88 Investment Partners's portfolio in Q2 2026, its #33 holding.
  • Pier 88 Investment Partners first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
  • Pier 88 Investment Partners's Guardant Health position peaked at $1.04M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Pier 88 Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.